Course of LVMI, LV GLS, LV ejection fraction, and stroke volume in AS and AR after AVR
| . | Patients with AS . | Patients with AR . | P value . |
|---|---|---|---|
| At baseline | N = 132 | N = 79 | |
| LVMI (g/m2) | 127.1 ± 36.0 | 154.9 ± 40.0 | <0.001a |
| LV GLS (%) | −15.1 ± 4.3 | −15.3 ± 4.1 | 0.685a |
| LVEF (%) | 55.9 ± 11.4 | 53.5 ± 9.1 | 0.117a |
| Stroke volume (mL) | 80.9 ± 22.4 | 115.4 ± 45.6 | <0.001a |
| At 1-year follow-up | N = 119 | N = 72 | |
| LVMI (g/m2) | 113.4 ± 31.6 | 126.1 ± 30.5 | 0.512b |
| LV GLS (%) | −15.0 ± 4.0 | −14.0 ± 3.9 | 0.014b |
| LVEF (%) | 55.1 ± 9.3 | 50.4 ± 9.7 | 0.310b |
| Stroke volume (mL) | 82.5 ± 22.4 | 82.9 ± 26.0 | <0.001b |
| At 2-year follow-up | N = 102 | N = 62 | |
| LVMI (g/m2) | 103.6 ± 26.6 | 110.3 ± 31.2 | 0.217b |
| LV GLS (%) | −16.8 ± 4.0 | −16.3 ± 4.1 | 0.133b |
| LVEF (%) | 56.4 ± 8.8 | 55.1 ± 8.6 | 0.158b |
| Stroke volume (mL) | 86.2 ± 20.1 | 89.2 ± 25.0 | 0.913b |
| At 5-year follow-up | N = 129 | N = 53 | |
| LVMI (g/m2) | 100.7 ± 28.8 | 104.7 ± 28.9 | 0.485b |
| LV GLS (%) | −17.2 ± 4.1 | −17.1 ± 3.6 | 0.301b |
| LVEF (%) | 56.8 ± 8.9 | 54.8 ± 8.1 | 0.255b |
| Stroke volume (mL) | 85.9 ± 23.5 | 85.9 ± 27.3 | 0.328b |
| . | Patients with AS . | Patients with AR . | P value . |
|---|---|---|---|
| At baseline | N = 132 | N = 79 | |
| LVMI (g/m2) | 127.1 ± 36.0 | 154.9 ± 40.0 | <0.001a |
| LV GLS (%) | −15.1 ± 4.3 | −15.3 ± 4.1 | 0.685a |
| LVEF (%) | 55.9 ± 11.4 | 53.5 ± 9.1 | 0.117a |
| Stroke volume (mL) | 80.9 ± 22.4 | 115.4 ± 45.6 | <0.001a |
| At 1-year follow-up | N = 119 | N = 72 | |
| LVMI (g/m2) | 113.4 ± 31.6 | 126.1 ± 30.5 | 0.512b |
| LV GLS (%) | −15.0 ± 4.0 | −14.0 ± 3.9 | 0.014b |
| LVEF (%) | 55.1 ± 9.3 | 50.4 ± 9.7 | 0.310b |
| Stroke volume (mL) | 82.5 ± 22.4 | 82.9 ± 26.0 | <0.001b |
| At 2-year follow-up | N = 102 | N = 62 | |
| LVMI (g/m2) | 103.6 ± 26.6 | 110.3 ± 31.2 | 0.217b |
| LV GLS (%) | −16.8 ± 4.0 | −16.3 ± 4.1 | 0.133b |
| LVEF (%) | 56.4 ± 8.8 | 55.1 ± 8.6 | 0.158b |
| Stroke volume (mL) | 86.2 ± 20.1 | 89.2 ± 25.0 | 0.913b |
| At 5-year follow-up | N = 129 | N = 53 | |
| LVMI (g/m2) | 100.7 ± 28.8 | 104.7 ± 28.9 | 0.485b |
| LV GLS (%) | −17.2 ± 4.1 | −17.1 ± 3.6 | 0.301b |
| LVEF (%) | 56.8 ± 8.9 | 54.8 ± 8.1 | 0.255b |
| Stroke volume (mL) | 85.9 ± 23.5 | 85.9 ± 27.3 | 0.328b |
AR, aortic regurgitation; AS, aortic stenosis; AVR, aortic valve replacement or repair; GLS, global longitudinal strain; LV, left ventricular; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index.
Calculated using the Student’s independent t-test.
Calculated using linear mixed models correcting for gender, age, LV end-diastolic diameter at baseline, and time between echocardiographic follow-up points.
Course of LVMI, LV GLS, LV ejection fraction, and stroke volume in AS and AR after AVR
| . | Patients with AS . | Patients with AR . | P value . |
|---|---|---|---|
| At baseline | N = 132 | N = 79 | |
| LVMI (g/m2) | 127.1 ± 36.0 | 154.9 ± 40.0 | <0.001a |
| LV GLS (%) | −15.1 ± 4.3 | −15.3 ± 4.1 | 0.685a |
| LVEF (%) | 55.9 ± 11.4 | 53.5 ± 9.1 | 0.117a |
| Stroke volume (mL) | 80.9 ± 22.4 | 115.4 ± 45.6 | <0.001a |
| At 1-year follow-up | N = 119 | N = 72 | |
| LVMI (g/m2) | 113.4 ± 31.6 | 126.1 ± 30.5 | 0.512b |
| LV GLS (%) | −15.0 ± 4.0 | −14.0 ± 3.9 | 0.014b |
| LVEF (%) | 55.1 ± 9.3 | 50.4 ± 9.7 | 0.310b |
| Stroke volume (mL) | 82.5 ± 22.4 | 82.9 ± 26.0 | <0.001b |
| At 2-year follow-up | N = 102 | N = 62 | |
| LVMI (g/m2) | 103.6 ± 26.6 | 110.3 ± 31.2 | 0.217b |
| LV GLS (%) | −16.8 ± 4.0 | −16.3 ± 4.1 | 0.133b |
| LVEF (%) | 56.4 ± 8.8 | 55.1 ± 8.6 | 0.158b |
| Stroke volume (mL) | 86.2 ± 20.1 | 89.2 ± 25.0 | 0.913b |
| At 5-year follow-up | N = 129 | N = 53 | |
| LVMI (g/m2) | 100.7 ± 28.8 | 104.7 ± 28.9 | 0.485b |
| LV GLS (%) | −17.2 ± 4.1 | −17.1 ± 3.6 | 0.301b |
| LVEF (%) | 56.8 ± 8.9 | 54.8 ± 8.1 | 0.255b |
| Stroke volume (mL) | 85.9 ± 23.5 | 85.9 ± 27.3 | 0.328b |
| . | Patients with AS . | Patients with AR . | P value . |
|---|---|---|---|
| At baseline | N = 132 | N = 79 | |
| LVMI (g/m2) | 127.1 ± 36.0 | 154.9 ± 40.0 | <0.001a |
| LV GLS (%) | −15.1 ± 4.3 | −15.3 ± 4.1 | 0.685a |
| LVEF (%) | 55.9 ± 11.4 | 53.5 ± 9.1 | 0.117a |
| Stroke volume (mL) | 80.9 ± 22.4 | 115.4 ± 45.6 | <0.001a |
| At 1-year follow-up | N = 119 | N = 72 | |
| LVMI (g/m2) | 113.4 ± 31.6 | 126.1 ± 30.5 | 0.512b |
| LV GLS (%) | −15.0 ± 4.0 | −14.0 ± 3.9 | 0.014b |
| LVEF (%) | 55.1 ± 9.3 | 50.4 ± 9.7 | 0.310b |
| Stroke volume (mL) | 82.5 ± 22.4 | 82.9 ± 26.0 | <0.001b |
| At 2-year follow-up | N = 102 | N = 62 | |
| LVMI (g/m2) | 103.6 ± 26.6 | 110.3 ± 31.2 | 0.217b |
| LV GLS (%) | −16.8 ± 4.0 | −16.3 ± 4.1 | 0.133b |
| LVEF (%) | 56.4 ± 8.8 | 55.1 ± 8.6 | 0.158b |
| Stroke volume (mL) | 86.2 ± 20.1 | 89.2 ± 25.0 | 0.913b |
| At 5-year follow-up | N = 129 | N = 53 | |
| LVMI (g/m2) | 100.7 ± 28.8 | 104.7 ± 28.9 | 0.485b |
| LV GLS (%) | −17.2 ± 4.1 | −17.1 ± 3.6 | 0.301b |
| LVEF (%) | 56.8 ± 8.9 | 54.8 ± 8.1 | 0.255b |
| Stroke volume (mL) | 85.9 ± 23.5 | 85.9 ± 27.3 | 0.328b |
AR, aortic regurgitation; AS, aortic stenosis; AVR, aortic valve replacement or repair; GLS, global longitudinal strain; LV, left ventricular; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index.
Calculated using the Student’s independent t-test.
Calculated using linear mixed models correcting for gender, age, LV end-diastolic diameter at baseline, and time between echocardiographic follow-up points.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
